Atopic dermatitis (AD) can have a significantly negative impact on quality of life (QoL). The impact of coronavirus disease 2019 (COVID-19) on the AD population is not yet well established. The study comprised 195 patients with diagnosed AD who were asked about their cognitive and preventive behaviors regarding COVID-19 and the accessibility of medical support, including online consultations. Moreover, the patients responded to the self-reported Dermatology Life Quality Index (DLQI) and Hospital Anxiety and Depression Scale (HADS). Most of the patients were worried about being infected with COVID-19. Most of the patients believed that people suffering from skin disease were more prone to be infected with COVID-19 compared with the general population. Most the patients negatively assessed the availability of dermatological treatment during the pandemic. Furthermore, 66.1% of the patients declared using telemedicine. Nearly 50% of patients were discontented with telemedicine, and 1/3 of the patients did not mind the use of telemedicine. AD during the COVID-19 pandemic was associated with a lower overall health rating and life satisfaction and impaired QoL related to mental health in a Polish population. These results provide original information that can be applied in dermatologic patient screenings to evaluate the state of depression and anxiety during the epidemic period.
【저자키워드】 COVID-19, coronavirus, Quality of life, atopic dermatitis, 【초록키워드】 Treatment, coronavirus disease, pandemic, Anxiety, Depression, mental health, COVID-19 pandemic, Screening, Health, Patient, General population, scale, Quality, information, disease, Satisfaction, life, Support, cognitive, index, MOST, HADS, the epidemic, evaluate, significantly, the patient, diagnosed, asked, infected with COVID-19, 【제목키워드】 Impact, dermatitis,